57524-89-7 Usage
Description
CORTISOL 17-VALERATE, also known as Hydrocortisone 17-Valerate, is a glucocorticoid derivative of Hydrocortisone, which is naturally produced by the zona fasciculata of the adrenal gland. It exhibits anti-inflammatory, immunosuppressive, and vasoconstrictive properties, making it a versatile compound with various applications in the medical field.
Uses
Used in Pharmaceutical Industry:
CORTISOL 17-VALERATE is used as an anti-inflammatory agent for reducing inflammation and alleviating the symptoms of various conditions, such as allergies, arthritis, and skin disorders. Its immunosuppressive properties also make it useful in treating autoimmune diseases and preventing organ transplant rejection.
Used in Dermatology:
In the field of dermatology, CORTISOL 17-VALERATE is used as a topical treatment for various skin conditions, such as eczema, psoriasis, and dermatitis. Its anti-inflammatory and vasoconstrictive effects help to reduce redness, swelling, and itching associated with these conditions.
Brand Name:
One of the brand names for CORTISOL 17-VALERATE is Westcort, which is manufactured by Westwood-Squibb. This brand is widely recognized and prescribed by healthcare professionals for its effectiveness in treating various inflammatory and immune-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 57524-89-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,5,2 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 57524-89:
(7*5)+(6*7)+(5*5)+(4*2)+(3*4)+(2*8)+(1*9)=147
147 % 10 = 7
So 57524-89-7 is a valid CAS Registry Number.
InChI:InChI=1/C26H38O6/c1-4-5-6-22(31)32-26(21(30)15-27)12-10-19-18-8-7-16-13-17(28)9-11-24(16,2)23(18)20(29)14-25(19,26)3/h13,18-20,23,27,29H,4-12,14-15H2,1-3H3/t18-,19-,20-,23+,24-,25-,26-/m0/s1
57524-89-7Relevant articles and documents
Additives enhancing topical corticosteroid action
-
, (2008/06/13)
Composition and method for enhancing therapeutic effects of corticosteroids to alleviate the symptoms of inflammation and exfoliation such as psoriasis, eczema, seborrheic dermatitis and other inflammatory skin conditions consisting of a solution, cream, lotion, ointment or gel containing as two active ingredients a corticosteroid and an additive are disclosed. The therapeutic composition may include one or more of corticosteroids typically present in a total amount of from 0.01 to 2 percent and one or more of hydroxy acids or related compounds present in a total amount from 0.01 to 2 percent by weight of the total composition. Topical application of the therapeutic composition in a solution, cream, lotion, gel or ointment has been found to achieve a substantial increase in antiinflammatory action of corticosteroids.
